Results 81 to 90 of about 489 (130)

Correction: Effect of Hepatic Impairment or Renal Impairment on the Pharmacokinetics of Aficamten. [PDF]

Clin Pharmacokinet
Xu D, Lutz JD, Divanji P, Li J, Benattia Y, Griffith A, Heitner SB, Kupfer S, German P.   +8 more
europepmc   +1 more source

Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy

JACC: Heart Failure
Sara Saberi, Theodore P. Abraham, Lubna Choudhury, Roberto Barriales-Villa, Perry M. Elliott, Michael E. Nassif, Artur Oreziak, Anjali T. Owens, Albree Tower-Rader, Florian Rader, Pablo Garcia-Pavia, Iacopo Olivotto, Caroline J. Coats, Michael A. Fifer, Mark V. Sherrid, Scott D. Solomon, Hugh Watkins, Stephen B. Heitner, Daniel L. Jacoby, Stuart Kupfer, Fady I. Malik, Chiara Melloni, Lisa Meng, Jenny Wei, Martin S. Maron, Ahmad Masri   +25 more
openaire   +1 more source

Emerging Pharmacological and Invasive Therapies for Hypertrophic Cardiomyopathy with Obstructive Physiology. [PDF]

Card Fail Rev
Li-Wen Chu E, Seung Kim D, Masri A.
europepmc   +1 more source

Cardiac myosin inhibitors in hypertrophic cardiomyopathy: advancing care with caution. [PDF]

Ann Med Surg (Lond)
Rehman Z, Ahsaan F, Latif B, Anjum AF, Yokolo H.   +4 more
europepmc   +1 more source

A plain language summary of the SEQUOIA-HCM study: aficamten for symptomatic obstructive hypertrophic cardiomyopathy. [PDF]

Future Cardiol
Maron MS, Olivotto I, van Sinttruije M.
europepmc   +1 more source

Cardiac myosin inhibitors in hypertrophic cardiomyopathy. [PDF]

J Cardiovasc Imaging
Lim J, Kim HK.
europepmc   +1 more source

Mavacamten in Symptomatic Hypertrophic Cardiomyopathy: A Paradigm Shift or Revolution? [PDF]

JACC Asia
Hung CL, Liu YW, Wu YW.
europepmc   +1 more source

Discovery of a novel cardiac-specific myosin modulator using artificial intelligence-based virtual screening [PDF]

, 2023
Attili, Seetharamaiah, Hoare, Zoe, Kampourakis, Thomas, Kenyon, Victor, Parijat, Priyanka, Shattock, Michael   +5 more
core   +3 more sources

Effect of Aficamten on Structure and Function in Patients with Obstructive Hypertrophic Cardiomyopathy: The FOREST-HCM CMR Sub-study

Journal of Cardiovascular Magnetic Resonance
Ahmad Masri, MD, Rhanderson Cardoso, MD, Theodore Abraham, MD, Lubna Choudhury, MD, Florian Rader, MD, Sara Saberi, MD, Albree Tower-Rader, MD, Andrew Wang, MD, Stephen Heitner, MD, Stuart Kupfer, MD, Fady Malik, MD, PhD, Chiara Melloni, MD, Jenny Wei, PhD, Amy Wohltman, Raymond Kwong, MD   +14 more
doaj   +1 more source

Cardiac myosin inhibitors - a cutting-edge solution for the management of hypertrophic cardiomyopathy: a narrative review. [PDF]

Ann Med Surg (Lond)
Younas A, Qadri M, Ijlal A, Khan T, Pirzada L, Kumari V, Mubbashir A, Singh PK, Sherwani MRK, Noor R, Nausheen F, Ahmad B, Rahim H, Akilimali A.   +13 more
europepmc   +1 more source